02:24 AM EDT, 08/27/2026 (MT Newswires) -- Bonesupport Holding (BONEX.ST) said Thursday that the US Food and Drug Administration extended the deadline for the submission of an additional data package for Cerament V to October. The listed orthobiologics company said the requested information will supplement previously submitted biocompatibility data for the injectable synthetic bone void filler.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.